2019 ஆம் ஆண்டிற்கான சிறந்த 10 செயல்திறன் துறை நிதி

Updated on September 1, 2025 , 655 views

துறைபரஸ்பர நிதி ஒரு குறிப்பிட்ட துறைக்குச் சொந்தமான நிறுவனங்களின் பங்கு பங்குகளில் தங்கள் நிதிப் பணத்தின் பெரும்பகுதியை முதலீடு செய்யும் திட்டத்தைப் பார்க்கவும். இந்த திட்டங்கள் தேடும் நபர்களால் தேடப்படுகின்றனஉயர் வருமானம் அவர்களின் முதலீட்டில் ஒருஅதிக ஆபத்து பசியின்மை. மியூச்சுவல் ஃபண்டுகள் பொதுவாக தங்கள் திட்டங்களை வழங்கும் சில துறைகளில் உள்கட்டமைப்பு, மருந்து, வங்கி மற்றும் நிதி சேவைகள் மற்றும் இயற்கை வளங்கள் மற்றும் புதிய ஆற்றல் ஆகியவை அடங்கும். 2019 ஆம் ஆண்டிற்கான துறை நிதிகளின் செயல்திறன் கணிசமாக சிறப்பாக உள்ளது. பொருளாதாரத்தின் வளர்ச்சியுடன், பல துறை நிதிகள் தங்கள் முதலீடுகளுக்கு சாதகமான வருமானத்தை ஈட்டியுள்ளன. எனவே, 2019 ஆம் ஆண்டிற்கான சிறந்த மற்றும் சிறந்த 10 செயல்திறன் துறை மியூச்சுவல் ஃபண்டுகளில் சிலவற்றை அவற்றின் செயல்திறன் (வருமானம்) அடிப்படையில் பார்ப்போம்.

Ready to Invest?
Talk to our investment specialist

செயல்திறனை அடிப்படையாகக் கொண்டு 2019 ஆம் ஆண்டிற்கான சிறந்த 10 செயல்திறன் துறை பரஸ்பர நிதிகள்

Fund	NAV	Net Assets (Cr)	2024 (%)	2023 (%)	2022 (%)	2021 (%)	2020 (%)
LIC MF Infrastructure Fund Growth	₹48.4222 ↓ -0.32	₹1,038	47.8	44.4	7.9	46.6	-0.1
UTI Healthcare Fund Growth	₹292.526 ↑ 0.58	₹1,146	42.9	38.2	-12.3	19.1	67.4
SBI Healthcare Opportunities Fund Growth	₹432.366 ↑ 3.22	₹4,027	42.2	38.2	-6	20.1	65.8
TATA India Pharma & Healthcare Fund Growth	₹30.7978 ↑ 0.01	₹1,339	40.4	36.6	-8	19.1	64.4
Bandhan Infrastructure Fund Growth	₹49.312 ↓ -0.39	₹1,676	39.3	50.3	1.7	64.8	6.3
Franklin India Opportunities Fund Growth	₹255.357 ↑ 1.17	₹7,376	37.3	53.6	-1.9	29.7	27.3
Canara Robeco Infrastructure Growth	₹159.3 ↓ -1.01	₹917	35.3	41.2	9	56.1	9
Nippon India Pharma Fund Growth	₹515.607 ↑ 1.46	₹8,737	34	39.2	-9.9	23.9	66.4
Invesco India Infrastructure Fund Growth	₹63.43 ↓ -0.37	₹1,569	33.2	51.1	2.3	55.4	16.2
Kotak Infrastructure & Economic Reform Fund Growth	₹64.405 ↓ -0.27	₹2,388	32.4	37.3	15.6	57.3	3.4
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Sep 25

Research Highlights & Commentary of 10 Funds showcased

Commentary	LIC MF Infrastructure Fund	UTI Healthcare Fund	SBI Healthcare Opportunities Fund	TATA India Pharma & Healthcare Fund	Bandhan Infrastructure Fund	Franklin India Opportunities Fund	Canara Robeco Infrastructure	Nippon India Pharma Fund	Invesco India Infrastructure Fund	Kotak Infrastructure & Economic Reform Fund
Point 1	Bottom quartile AUM (₹1,038 Cr).	Bottom quartile AUM (₹1,146 Cr).	Upper mid AUM (₹4,027 Cr).	Lower mid AUM (₹1,339 Cr).	Upper mid AUM (₹1,676 Cr).	Top quartile AUM (₹7,376 Cr).	Bottom quartile AUM (₹917 Cr).	Highest AUM (₹8,737 Cr).	Lower mid AUM (₹1,569 Cr).	Upper mid AUM (₹2,388 Cr).
Point 2	Established history (17+ yrs).	Oldest track record among peers (26 yrs).	Established history (20+ yrs).	Established history (9+ yrs).	Established history (14+ yrs).	Established history (25+ yrs).	Established history (19+ yrs).	Established history (21+ yrs).	Established history (17+ yrs).	Established history (17+ yrs).
Point 3	Not Rated.	Rating: 1★ (lower mid).	Rating: 2★ (upper mid).	Not Rated.	Top rated.	Rating: 3★ (upper mid).	Not Rated.	Rating: 2★ (lower mid).	Rating: 3★ (upper mid).	Rating: 4★ (top quartile).
Point 4	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: Moderately High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.
Point 5	5Y return: 30.51% (upper mid).	5Y return: 18.68% (bottom quartile).	5Y return: 20.54% (lower mid).	5Y return: 18.95% (bottom quartile).	5Y return: 32.05% (top quartile).	5Y return: 28.43% (lower mid).	5Y return: 30.89% (top quartile).	5Y return: 18.70% (bottom quartile).	5Y return: 29.06% (upper mid).	5Y return: 29.48% (upper mid).
Point 6	3Y return: 26.45% (upper mid).	3Y return: 25.64% (upper mid).	3Y return: 26.65% (top quartile).	3Y return: 24.07% (lower mid).	3Y return: 26.36% (upper mid).	3Y return: 28.60% (top quartile).	3Y return: 23.81% (bottom quartile).	3Y return: 23.31% (bottom quartile).	3Y return: 25.28% (lower mid).	3Y return: 21.21% (bottom quartile).
Point 7	1Y return: -6.79% (bottom quartile).	1Y return: 3.87% (top quartile).	1Y return: 6.02% (top quartile).	1Y return: 0.12% (upper mid).	1Y return: -10.95% (bottom quartile).	1Y return: 0.07% (upper mid).	1Y return: -2.00% (lower mid).	1Y return: -0.46% (upper mid).	1Y return: -5.70% (lower mid).	1Y return: -8.73% (bottom quartile).
Point 8	Alpha: 1.35 (upper mid).	Alpha: 0.67 (upper mid).	Alpha: 3.04 (top quartile).	Alpha: 2.48 (top quartile).	Alpha: 0.00 (lower mid).	Alpha: 1.79 (upper mid).	Alpha: 0.00 (lower mid).	Alpha: -3.24 (bottom quartile).	Alpha: 0.00 (bottom quartile).	Alpha: -3.87 (bottom quartile).
Point 9	Sharpe: -0.30 (upper mid).	Sharpe: 0.43 (top quartile).	Sharpe: 0.60 (top quartile).	Sharpe: 0.16 (upper mid).	Sharpe: -0.69 (bottom quartile).	Sharpe: -0.30 (lower mid).	Sharpe: -0.36 (lower mid).	Sharpe: 0.18 (upper mid).	Sharpe: -0.38 (bottom quartile).	Sharpe: -0.54 (bottom quartile).
Point 10	Information ratio: 0.40 (upper mid).	Information ratio: -0.06 (bottom quartile).	Information ratio: 0.38 (upper mid).	Information ratio: 0.60 (top quartile).	Information ratio: 0.00 (lower mid).	Information ratio: 1.83 (top quartile).	Information ratio: 0.00 (lower mid).	Information ratio: -0.51 (bottom quartile).	Information ratio: 0.00 (bottom quartile).	Information ratio: 0.05 (upper mid).

LIC MF Infrastructure Fund

Bottom quartile AUM (₹1,038 Cr).
Established history (17+ yrs).
Not Rated.
Risk profile: High.
5Y return: 30.51% (upper mid).
3Y return: 26.45% (upper mid).
1Y return: -6.79% (bottom quartile).
Alpha: 1.35 (upper mid).
Sharpe: -0.30 (upper mid).
Information ratio: 0.40 (upper mid).

UTI Healthcare Fund

Bottom quartile AUM (₹1,146 Cr).
Oldest track record among peers (26 yrs).
Rating: 1★ (lower mid).
Risk profile: High.
5Y return: 18.68% (bottom quartile).
3Y return: 25.64% (upper mid).
1Y return: 3.87% (top quartile).
Alpha: 0.67 (upper mid).
Sharpe: 0.43 (top quartile).
Information ratio: -0.06 (bottom quartile).

SBI Healthcare Opportunities Fund

Upper mid AUM (₹4,027 Cr).
Established history (20+ yrs).
Rating: 2★ (upper mid).
Risk profile: High.
5Y return: 20.54% (lower mid).
3Y return: 26.65% (top quartile).
1Y return: 6.02% (top quartile).
Alpha: 3.04 (top quartile).
Sharpe: 0.60 (top quartile).
Information ratio: 0.38 (upper mid).

TATA India Pharma & Healthcare Fund

Lower mid AUM (₹1,339 Cr).
Established history (9+ yrs).
Not Rated.
Risk profile: High.
5Y return: 18.95% (bottom quartile).
3Y return: 24.07% (lower mid).
1Y return: 0.12% (upper mid).
Alpha: 2.48 (top quartile).
Sharpe: 0.16 (upper mid).
Information ratio: 0.60 (top quartile).

Bandhan Infrastructure Fund

Upper mid AUM (₹1,676 Cr).
Established history (14+ yrs).
Top rated.
Risk profile: High.
5Y return: 32.05% (top quartile).
3Y return: 26.36% (upper mid).
1Y return: -10.95% (bottom quartile).
Alpha: 0.00 (lower mid).
Sharpe: -0.69 (bottom quartile).
Information ratio: 0.00 (lower mid).

Franklin India Opportunities Fund

Top quartile AUM (₹7,376 Cr).
Established history (25+ yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 28.43% (lower mid).
3Y return: 28.60% (top quartile).
1Y return: 0.07% (upper mid).
Alpha: 1.79 (upper mid).
Sharpe: -0.30 (lower mid).
Information ratio: 1.83 (top quartile).

Canara Robeco Infrastructure

Bottom quartile AUM (₹917 Cr).
Established history (19+ yrs).
Not Rated.
Risk profile: High.
5Y return: 30.89% (top quartile).
3Y return: 23.81% (bottom quartile).
1Y return: -2.00% (lower mid).
Alpha: 0.00 (lower mid).
Sharpe: -0.36 (lower mid).
Information ratio: 0.00 (lower mid).

Nippon India Pharma Fund

Highest AUM (₹8,737 Cr).
Established history (21+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 18.70% (bottom quartile).
3Y return: 23.31% (bottom quartile).
1Y return: -0.46% (upper mid).
Alpha: -3.24 (bottom quartile).
Sharpe: 0.18 (upper mid).
Information ratio: -0.51 (bottom quartile).

Invesco India Infrastructure Fund

Lower mid AUM (₹1,569 Cr).
Established history (17+ yrs).
Rating: 3★ (upper mid).
Risk profile: High.
5Y return: 29.06% (upper mid).
3Y return: 25.28% (lower mid).
1Y return: -5.70% (lower mid).
Alpha: 0.00 (bottom quartile).
Sharpe: -0.38 (bottom quartile).
Information ratio: 0.00 (bottom quartile).

Kotak Infrastructure & Economic Reform Fund

Upper mid AUM (₹2,388 Cr).
Established history (17+ yrs).
Rating: 4★ (top quartile).
Risk profile: High.
5Y return: 29.48% (upper mid).
3Y return: 21.21% (bottom quartile).
1Y return: -8.73% (bottom quartile).
Alpha: -3.87 (bottom quartile).
Sharpe: -0.54 (bottom quartile).
Information ratio: 0.05 (upper mid).

2019 ஆம் ஆண்டிற்கான சிறந்த செயல்திறன் துறை நிதி

1. LIC MF Infrastructure Fund

The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector.

Research Highlights for LIC MF Infrastructure Fund

Bottom quartile AUM (₹1,038 Cr).
Established history (17+ yrs).
Not Rated.
Risk profile: High.
5Y return: 30.51% (upper mid).
3Y return: 26.45% (upper mid).
1Y return: -6.79% (bottom quartile).
Alpha: 1.35 (upper mid).
Sharpe: -0.30 (upper mid).
Information ratio: 0.40 (upper mid).
Top sector: Industrials.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~95%).
High-quality debt (AAA/AA ~100%).
Largest holding Shakti Pumps (India) Ltd (~6.0%).

Below is the key information for LIC MF Infrastructure Fund

LIC MF Infrastructure Fund Growth
Launch Date	29 Feb 08
NAV (04 Sep 25)	₹48.4222 ↓ -0.32 (-0.66 %)
Net Assets (Cr)	₹1,038 on 31 Jul 25
Category	Equity - Sectoral
AMC	LIC Mutual Fund Asset Mgmt Co Ltd
Rating	Not Rated
Risk	High
Expense Ratio	2.21
Sharpe Ratio	-0.3
Information Ratio	0.4
Alpha Ratio	1.35
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹16,396
31 Aug 22	₹18,753
31 Aug 23	₹23,082
31 Aug 24	₹41,121
31 Aug 25	₹37,159

LIC MF Infrastructure Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹642,208.
Net Profit of ₹342,208 Invest Now

Returns for LIC MF Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	-1%
3 Month	-0.8%
6 Month	24.6%
1 Year	-6.8%
3 Year	26.4%
5 Year	30.5%
10 Year
15 Year
Since launch	9.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	47.8%
2023	44.4%
2022	7.9%
2021	46.6%
2020	-0.1%
2019	13.3%
2018	-14.6%
2017	42.2%
2016	-2.2%
2015	-6.2%

Fund Manager information for LIC MF Infrastructure Fund

Name	Since	Tenure
Yogesh Patil	18 Sep 20	4.96 Yr.
Mahesh Bendre	1 Jul 24	1.17 Yr.

Data below for LIC MF Infrastructure Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Industrials	49.62%
Basic Materials	8.63%
Financial Services	8.16%
Consumer Cyclical	6.96%
Utility	6.68%
Technology	4.17%
Health Care	3.87%
Real Estate	3.65%
Communication Services	2.48%
Energy	0.92%

Asset Allocation

Asset Class	Value
Cash	4.87%
Equity	95.13%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Shakti Pumps (India) Ltd (Industrials) Equity, Since 31 Mar 24 \| SHAKTIPUMP	6%	₹62 Cr	693,857 ↑ 217,865
Larsen & Toubro Ltd (Industrials) Equity, Since 30 Apr 09 \| LT	4%	₹40 Cr	109,584 ↑ 6,093
REC Ltd (Financial Services) Equity, Since 31 Jul 23 \| 532955	3%	₹36 Cr	911,009 ↑ 289,485
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Jun 25 \| APOLLOHOSP	3%	₹35 Cr	46,843 ↑ 6,976
Garware Hi-Tech Films Ltd (Basic Materials) Equity, Since 31 Aug 23 \| 500655	3%	₹33 Cr	94,287
Schneider Electric Infrastructure Ltd (Industrials) Equity, Since 31 Dec 23 \| SCHNEIDER	3%	₹32 Cr	319,302
Afcons Infrastructure Ltd (Industrials) Equity, Since 31 Oct 24 \| AFCONS	3%	₹31 Cr	769,765
Tata Power Co Ltd (Utilities) Equity, Since 29 Feb 24 \| 500400	3%	₹29 Cr	724,927
Avalon Technologies Ltd (Technology) Equity, Since 31 Jul 23 \| AVALON	3%	₹26 Cr	310,615 ↓ -6,871
Mahindra Lifespace Developers Ltd (Real Estate) Equity, Since 30 Jun 24 \| MAHLIFE	2%	₹25 Cr	666,245

2. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

Research Highlights for UTI Healthcare Fund

Bottom quartile AUM (₹1,146 Cr).
Oldest track record among peers (26 yrs).
Rating: 1★ (lower mid).
Risk profile: High.
5Y return: 18.68% (bottom quartile).
3Y return: 25.64% (upper mid).
1Y return: 3.87% (top quartile).
Alpha: 0.67 (upper mid).
Sharpe: 0.43 (top quartile).
Information ratio: -0.06 (bottom quartile).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~98%).
High-quality debt (AAA/AA ~100%).
Largest holding Sun Pharmaceuticals Industries Ltd (~9.8%).

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund Growth
Launch Date	28 Jun 99
NAV (04 Sep 25)	₹292.526 ↑ 0.58 (0.20 %)
Net Assets (Cr)	₹1,146 on 31 Jul 25
Category	Equity - Sectoral
AMC	UTI Asset Management Company Ltd
Rating	☆
Risk	High
Expense Ratio	2.26
Sharpe Ratio	0.43
Information Ratio	-0.06
Alpha Ratio	0.67
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹14,183
31 Aug 22	₹12,385
31 Aug 23	₹15,093
31 Aug 24	₹23,487
31 Aug 25	₹24,105

UTI Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹481,656.
Net Profit of ₹181,656 Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.2%
3 Month	5.4%
6 Month	17.7%
1 Year	3.9%
3 Year	25.6%
5 Year	18.7%
10 Year
15 Year
Since launch	15%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	42.9%
2023	38.2%
2022	-12.3%
2021	19.1%
2020	67.4%
2019	1.2%
2018	-7.5%
2017	6.2%
2016	-9.7%
2015	12.4%

Fund Manager information for UTI Healthcare Fund

Name	Since	Tenure
Kamal Gada	2 May 22	3.34 Yr.

Data below for UTI Healthcare Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Health Care	96.62%
Basic Materials	1.03%

Asset Allocation

Asset Class	Value
Cash	2.34%
Equity	97.66%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	10%	₹113 Cr	661,016
Cipla Ltd (Healthcare) Equity, Since 31 Jan 03 \| 500087	5%	₹62 Cr	400,000
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| 532331	5%	₹55 Cr	200,000 ↓ -10,000
Lupin Ltd (Healthcare) Equity, Since 28 Feb 25 \| 500257	4%	₹49 Cr	255,000 ↑ 55,000
Procter & Gamble Health Ltd (Healthcare) Equity, Since 31 Dec 20 \| PGHL	4%	₹47 Cr	80,283
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| DRREDDY	4%	₹46 Cr	360,000
Glenmark Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Mar 24 \| 532296	4%	₹41 Cr	190,000 ↓ -60,000
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Dec 20 \| 532843	3%	₹40 Cr	465,000
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Apr 21 \| APOLLOHOSP	3%	₹40 Cr	53,000
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	3%	₹34 Cr	166,863 ↓ -13,137

3. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

Research Highlights for SBI Healthcare Opportunities Fund

Upper mid AUM (₹4,027 Cr).
Established history (20+ yrs).
Rating: 2★ (upper mid).
Risk profile: High.
5Y return: 20.54% (lower mid).
3Y return: 26.65% (top quartile).
1Y return: 6.02% (top quartile).
Alpha: 3.04 (top quartile).
Sharpe: 0.60 (top quartile).
Information ratio: 0.38 (upper mid).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~98%).
High-quality debt (AAA/AA ~100%).
Largest holding Sun Pharmaceuticals Industries Ltd (~11.4%).

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund Growth
Launch Date	31 Dec 04
NAV (03 Sep 25)	₹432.366 ↑ 3.22 (0.75 %)
Net Assets (Cr)	₹4,027 on 31 Jul 25
Category	Equity - Sectoral
AMC	SBI Funds Management Private Limited
Rating	☆☆
Risk	High
Expense Ratio	1.97
Sharpe Ratio	0.6
Information Ratio	0.38
Alpha Ratio	3.04
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹14,180
31 Aug 22	₹12,913
31 Aug 23	₹16,856
31 Aug 24	₹24,718
31 Aug 25	₹25,879

SBI Healthcare Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹505,644.
Net Profit of ₹205,644 Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	-0.1%
3 Month	3.9%
6 Month	12.5%
1 Year	6%
3 Year	26.7%
5 Year	20.5%
10 Year
15 Year
Since launch	15.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	42.2%
2023	38.2%
2022	-6%
2021	20.1%
2020	65.8%
2019	-0.5%
2018	-9.9%
2017	2.1%
2016	-14%
2015	27.1%

Fund Manager information for SBI Healthcare Opportunities Fund

Name	Since	Tenure
Tanmaya Desai	1 Jun 11	14.26 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Health Care	91.66%
Basic Materials	5.96%

Asset Allocation

Asset Class	Value
Cash	2.31%
Equity	97.62%
Debt	0.07%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Dec 17 \| SUNPHARMA	11%	₹461 Cr	2,700,000 ↓ -100,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	7%	₹290 Cr	440,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 21 \| MAXHEALTH	6%	₹262 Cr	2,100,000
Cipla Ltd (Healthcare) Equity, Since 31 Aug 16 \| 500087	5%	₹187 Cr	1,200,000
Lonza Group Ltd ADR (Healthcare) Equity, Since 31 Jan 24 \| LZAGY	4%	₹165 Cr	270,000 ↓ -30,000
Lupin Ltd (Healthcare) Equity, Since 31 Aug 23 \| 500257	4%	₹162 Cr	840,000
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	4%	₹145 Cr	700,000 ↑ 160,000
Mankind Pharma Ltd (Healthcare) Equity, Since 30 Apr 23 \| MANKIND	4%	₹144 Cr	560,000
Acutaas Chemicals Ltd (Basic Materials) Equity, Since 30 Jun 24 \| 543349	3%	₹133 Cr	1,000,000
Krishna Institute of Medical Sciences Ltd (Healthcare) Equity, Since 30 Nov 22 \| 543308	3%	₹131 Cr	1,750,000 ↓ -50,000

4. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

Research Highlights for TATA India Pharma & Healthcare Fund

Lower mid AUM (₹1,339 Cr).
Established history (9+ yrs).
Not Rated.
Risk profile: High.
5Y return: 18.95% (bottom quartile).
3Y return: 24.07% (lower mid).
1Y return: 0.12% (upper mid).
Alpha: 2.48 (top quartile).
Sharpe: 0.16 (upper mid).
Information ratio: 0.60 (top quartile).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~94%).
Largest holding Sun Pharmaceuticals Industries Ltd (~10.9%).

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund Growth
Launch Date	28 Dec 15
NAV (04 Sep 25)	₹30.7978 ↑ 0.01 (0.03 %)
Net Assets (Cr)	₹1,339 on 31 Jul 25
Category	Equity - Sectoral
AMC	Tata Asset Management Limited
Rating	Not Rated
Risk	High
Expense Ratio	2.17
Sharpe Ratio	0.16
Information Ratio	0.6
Alpha Ratio	2.48
Min Investment	5,000
Min SIP Investment	150
Exit Load	0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹14,514
31 Aug 22	₹12,943
31 Aug 23	₹15,786
31 Aug 24	₹24,599
31 Aug 25	₹24,182

TATA India Pharma & Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹481,656.
Net Profit of ₹181,656 Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.6%
3 Month	5.3%
6 Month	15.4%
1 Year	0.1%
3 Year	24.1%
5 Year	19%
10 Year
15 Year
Since launch	12.3%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	40.4%
2023	36.6%
2022	-8%
2021	19.1%
2020	64.4%
2019	5.5%
2018	-2.6%
2017	4.7%
2016	-14.7%
2015

Fund Manager information for TATA India Pharma & Healthcare Fund

Name	Since	Tenure
Rajat Srivastava	16 Sep 24	0.96 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Health Care	91.69%
Financial Services	1.63%
Basic Materials	0.46%

Asset Allocation

Asset Class	Value
Cash	6.22%
Equity	93.78%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Jan 16 \| SUNPHARMA	11%	₹146 Cr	856,462 ↑ 2,162
Cipla Ltd (Healthcare) Equity, Since 30 Apr 20 \| 500087	7%	₹89 Cr	569,903 ↑ 79,903
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Dec 16 \| APOLLOHOSP	5%	₹70 Cr	92,826 ↓ -34,429
Lupin Ltd (Healthcare) Equity, Since 30 Nov 17 \| 500257	5%	₹64 Cr	330,887 ↑ 27,647
HealthCare Global Enterprises Ltd (Healthcare) Equity, Since 31 Dec 18 \| HCG	4%	₹59 Cr	942,453 ↑ 276,332
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Aug 22 \| TORNTPHARM	4%	₹58 Cr	154,717 ↑ 83,796
Aster DM Healthcare Ltd Ordinary Shares (Healthcare) Equity, Since 31 Dec 22 \| ASTERDM	4%	₹58 Cr	956,991
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Oct 20 \| 532843	4%	₹54 Cr	624,597 ↓ -230,503
Alkem Laboratories Ltd (Healthcare) Equity, Since 31 Aug 20 \| ALKEM	4%	₹54 Cr	106,435 ↑ 31,186
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Jul 25 \| MAXHEALTH	4%	₹51 Cr	407,917 ↑ 407,917

5. Bandhan Infrastructure Fund

The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized.

Research Highlights for Bandhan Infrastructure Fund

Upper mid AUM (₹1,676 Cr).
Established history (14+ yrs).
Top rated.
Risk profile: High.
5Y return: 32.05% (top quartile).
3Y return: 26.36% (upper mid).
1Y return: -10.95% (bottom quartile).
Alpha: 0.00 (lower mid).
Sharpe: -0.69 (bottom quartile).
Information ratio: 0.00 (lower mid).
Higher exposure to Industrials vs peer median.
Higher exposure to Cash Equivalent (bond sector) vs peer median.
Equity-heavy allocation (~91%).
Largest holding Kirloskar Brothers Ltd (~5.2%).

Below is the key information for Bandhan Infrastructure Fund

Bandhan Infrastructure Fund Growth
Launch Date	8 Mar 11
NAV (04 Sep 25)	₹49.312 ↓ -0.39 (-0.78 %)
Net Assets (Cr)	₹1,676 on 31 Jul 25
Category	Equity - Sectoral
AMC	IDFC Asset Management Company Limited
Rating	☆☆☆☆☆
Risk	High
Expense Ratio	2.1
Sharpe Ratio	-0.69
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	100
Exit Load	0-365 Days (1%),365 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹19,221
31 Aug 22	₹20,185
31 Aug 23	₹26,032
31 Aug 24	₹45,976
31 Aug 25	₹39,818

Bandhan Infrastructure Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹673,113.
Net Profit of ₹373,113 Invest Now

Returns for Bandhan Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.3%
3 Month	-1%
6 Month	22.2%
1 Year	-10.9%
3 Year	26.4%
5 Year	32%
10 Year
15 Year
Since launch	11.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	39.3%
2023	50.3%
2022	1.7%
2021	64.8%
2020	6.3%
2019	-5.3%
2018	-25.9%
2017	58.7%
2016	10.7%
2015	-0.2%

Fund Manager information for Bandhan Infrastructure Fund

Name	Since	Tenure
Vishal Biraia	24 Jan 24	1.6 Yr.
Ritika Behera	7 Oct 23	1.9 Yr.
Gaurav Satra	7 Jun 24	1.24 Yr.

Data below for Bandhan Infrastructure Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Industrials	52.91%
Utility	12.23%
Basic Materials	7.2%
Communication Services	4.75%
Energy	3.76%
Financial Services	3.28%
Health Care	2.19%
Technology	1.74%
Consumer Cyclical	1.38%
Real Estate	1.08%

Asset Allocation

Asset Class	Value
Cash	9.47%
Equity	90.53%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Kirloskar Brothers Ltd (Industrials) Equity, Since 31 Dec 17 \| KIRLOSBROS	5%	₹87 Cr	443,385
Larsen & Toubro Ltd (Industrials) Equity, Since 29 Feb 12 \| LT	4%	₹75 Cr	206,262
Bharti Airtel Ltd (Communication Services) Equity, Since 30 Apr 19 \| BHARTIARTL	4%	₹63 Cr	330,018
Reliance Industries Ltd (Energy) Equity, Since 30 Jun 24 \| RELIANCE	4%	₹63 Cr	452,706
UltraTech Cement Ltd (Basic Materials) Equity, Since 31 Mar 14 \| 532538	4%	₹61 Cr	49,772 ↓ -680
GPT Infraprojects Ltd (Industrials) Equity, Since 30 Nov 17 \| GPTINFRA	4%	₹61 Cr	4,733,244 ↓ -49,289
Bharat Electronics Ltd (Industrials) Equity, Since 31 Oct 19 \| BEL	3%	₹55 Cr	1,431,700
PTC India Financial Services Ltd (Financial Services) Equity, Since 31 Dec 23 \| PFS	3%	₹52 Cr	12,400,122
Adani Ports & Special Economic Zone Ltd (Industrials) Equity, Since 31 Dec 23 \| ADANIPORTS	3%	₹50 Cr	365,137
Ahluwalia Contracts (India) Ltd (Industrials) Equity, Since 30 Apr 15 \| AHLUCONT	3%	₹47 Cr	462,606

6. Franklin India Opportunities Fund

The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy.

Research Highlights for Franklin India Opportunities Fund

Top quartile AUM (₹7,376 Cr).
Established history (25+ yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 28.43% (lower mid).
3Y return: 28.60% (top quartile).
1Y return: 0.07% (upper mid).
Alpha: 1.79 (upper mid).
Sharpe: -0.30 (lower mid).
Information ratio: 1.83 (top quartile).
Higher exposure to Financial Services vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~94%).
High-quality debt (AAA/AA ~100%).
Largest holding HDFC Bank Ltd (~5.6%).

Below is the key information for Franklin India Opportunities Fund

Franklin India Opportunities Fund Growth
Launch Date	21 Feb 00
NAV (03 Sep 25)	₹255.357 ↑ 1.17 (0.46 %)
Net Assets (Cr)	₹7,376 on 31 Jul 25
Category	Equity - Sectoral
AMC	Franklin Templeton Asst Mgmt(IND)Pvt Ltd
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	1.83
Sharpe Ratio	-0.3
Information Ratio	1.83
Alpha Ratio	1.79
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹16,290
31 Aug 22	₹16,765
31 Aug 23	₹21,341
31 Aug 24	₹35,884
31 Aug 25	₹35,247

Franklin India Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹612,552.
Net Profit of ₹312,552 Invest Now

Returns for Franklin India Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	2.4%
3 Month	4.4%
6 Month	20%
1 Year	0.1%
3 Year	28.6%
5 Year	28.4%
10 Year
15 Year
Since launch	13.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	37.3%
2023	53.6%
2022	-1.9%
2021	29.7%
2020	27.3%
2019	5.4%
2018	-10.1%
2017	35.6%
2016	4.2%
2015	2.3%

Fund Manager information for Franklin India Opportunities Fund

Name	Since	Tenure
Kiran Sebastian	7 Feb 22	3.57 Yr.
R. Janakiraman	1 Apr 13	12.43 Yr.
Sandeep Manam	18 Oct 21	3.87 Yr.

Data below for Franklin India Opportunities Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Financial Services	19.78%
Consumer Cyclical	18.45%
Health Care	14.12%
Technology	11.61%
Basic Materials	9.22%
Communication Services	5.73%
Energy	5.1%
Industrials	4.14%
Utility	2.87%
Consumer Defensive	1.83%
Real Estate	0.84%

Asset Allocation

Asset Class	Value
Cash	6.31%
Equity	93.69%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
HDFC Bank Ltd (Financial Services) Equity, Since 31 May 24 \| HDFCBANK	6%	₹413 Cr	2,043,971
Reliance Industries Ltd (Energy) Equity, Since 30 Apr 22 \| RELIANCE	5%	₹376 Cr	2,707,279 ↓ -331,689
Axis Bank Ltd (Financial Services) Equity, Since 30 Apr 25 \| 532215	4%	₹315 Cr	2,950,277
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Aug 23 \| 543320	4%	₹294 Cr	9,548,090 ↓ -582,172
Mphasis Ltd (Technology) Equity, Since 30 Nov 24 \| 526299	3%	₹227 Cr	814,231 ↑ 103,698
Bharti Airtel Ltd (Communication Services) Equity, Since 31 Jan 24 \| BHARTIARTL	3%	₹222 Cr	1,158,502 ↓ -183,731
Maruti Suzuki India Ltd (Consumer Cyclical) Equity, Since 30 Apr 25 \| MARUTI	3%	₹214 Cr	169,582
NTPC Ltd (Utilities) Equity, Since 31 Aug 22 \| 532555	3%	₹212 Cr	6,333,312
Sudarshan Chemical Industries Ltd (Basic Materials) Equity, Since 30 Apr 24 \| SUDARSCHEM	3%	₹206 Cr	1,435,340
Mahindra & Mahindra Ltd (Consumer Cyclical) Equity, Since 31 May 24 \| M&M	3%	₹204 Cr	637,966

7. Canara Robeco Infrastructure

T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized.

Research Highlights for Canara Robeco Infrastructure

Bottom quartile AUM (₹917 Cr).
Established history (19+ yrs).
Not Rated.
Risk profile: High.
5Y return: 30.89% (top quartile).
3Y return: 23.81% (bottom quartile).
1Y return: -2.00% (lower mid).
Alpha: 0.00 (lower mid).
Sharpe: -0.36 (lower mid).
Information ratio: 0.00 (lower mid).
Top sector: Industrials.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~96%).
Largest holding Larsen & Toubro Ltd (~7.8%).

Below is the key information for Canara Robeco Infrastructure

Canara Robeco Infrastructure Growth
Launch Date	2 Dec 05
NAV (04 Sep 25)	₹159.3 ↓ -1.01 (-0.63 %)
Net Assets (Cr)	₹917 on 31 Jul 25
Category	Equity - Sectoral
AMC	Canara Robeco Asset Management Co. Ltd.
Rating	Not Rated
Risk	High
Expense Ratio	2.32
Sharpe Ratio	-0.36
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹17,138
31 Aug 22	₹20,330
31 Aug 23	₹23,805
31 Aug 24	₹39,908
31 Aug 25	₹38,048

Canara Robeco Infrastructure SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹642,208.
Net Profit of ₹342,208 Invest Now

Returns for Canara Robeco Infrastructure

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.4%
3 Month	1.3%
6 Month	22.5%
1 Year	-2%
3 Year	23.8%
5 Year	30.9%
10 Year
15 Year
Since launch	15.1%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	35.3%
2023	41.2%
2022	9%
2021	56.1%
2020	9%
2019	2.3%
2018	-19.1%
2017	40.2%
2016	2.1%
2015	6.7%

Fund Manager information for Canara Robeco Infrastructure

Name	Since	Tenure
Vishal Mishra	26 Jun 21	4.19 Yr.
Shridatta Bhandwaldar	29 Sep 18	6.93 Yr.

Data below for Canara Robeco Infrastructure as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Industrials	45.06%
Utility	12.61%
Basic Materials	10.12%
Energy	8.15%
Financial Services	6.69%
Technology	5.72%
Consumer Cyclical	2.94%
Communication Services	2.85%
Real Estate	1.37%

Asset Allocation

Asset Class	Value
Cash	4.48%
Equity	95.52%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Larsen & Toubro Ltd (Industrials) Equity, Since 28 Feb 11 \| LT	8%	₹72 Cr	197,901 ↑ 5,000
Reliance Industries Ltd (Energy) Equity, Since 30 Apr 22 \| RELIANCE	4%	₹39 Cr	279,250 ↑ 15,000
NTPC Ltd (Utilities) Equity, Since 30 Nov 18 \| 532555	4%	₹36 Cr	1,066,480
InterGlobe Aviation Ltd (Industrials) Equity, Since 31 Jan 23 \| INDIGO	4%	₹34 Cr	58,250
State Bank of India (Financial Services) Equity, Since 31 Jul 24 \| SBIN	4%	₹34 Cr	430,000
Bharat Electronics Ltd (Industrials) Equity, Since 31 Jul 19 \| BEL	4%	₹33 Cr	869,000 ↓ -50,000
GE Vernova T&D India Ltd (Industrials) Equity, Since 31 Jan 24 \| 522275	4%	₹33 Cr	119,833 ↓ -3,000
Dixon Technologies (India) Ltd (Technology) Equity, Since 31 Oct 23 \| DIXON	3%	₹32 Cr	18,950 ↑ 1,750
Tata Power Co Ltd (Utilities) Equity, Since 30 Sep 24 \| 500400	3%	₹31 Cr	785,000
Power Grid Corp Of India Ltd (Utilities) Equity, Since 31 Oct 09 \| 532898	3%	₹28 Cr	957,546

8. Nippon India Pharma Fund

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Research Highlights for Nippon India Pharma Fund

Highest AUM (₹8,737 Cr).
Established history (21+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 18.70% (bottom quartile).
3Y return: 23.31% (bottom quartile).
1Y return: -0.46% (upper mid).
Alpha: -3.24 (bottom quartile).
Sharpe: 0.18 (upper mid).
Information ratio: -0.51 (bottom quartile).
Higher exposure to Health Care vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~99%).
Largest holding Sun Pharmaceuticals Industries Ltd (~12.2%).

Below is the key information for Nippon India Pharma Fund

Nippon India Pharma Fund Growth
Launch Date	5 Jun 04
NAV (04 Sep 25)	₹515.607 ↑ 1.46 (0.28 %)
Net Assets (Cr)	₹8,737 on 31 Jul 25
Category	Equity - Sectoral
AMC	Nippon Life Asset Management Ltd.
Rating	☆☆
Risk	High
Expense Ratio	1.81
Sharpe Ratio	0.18
Information Ratio	-0.51
Alpha Ratio	-3.24
Min Investment	5,000
Min SIP Investment	100
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹14,796
31 Aug 22	₹12,973
31 Aug 23	₹16,262
31 Aug 24	₹24,360
31 Aug 25	₹23,858

Nippon India Pharma Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹481,656.
Net Profit of ₹181,656 Invest Now

Returns for Nippon India Pharma Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	-0.5%
3 Month	2.4%
6 Month	12.8%
1 Year	-0.5%
3 Year	23.3%
5 Year	18.7%
10 Year
15 Year
Since launch	20.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	34%
2023	39.2%
2022	-9.9%
2021	23.9%
2020	66.4%
2019	1.7%
2018	3.6%
2017	7.6%
2016	-10.6%
2015	19.4%

Fund Manager information for Nippon India Pharma Fund

Name	Since	Tenure
Sailesh Raj Bhan	1 Apr 05	20.43 Yr.
Kinjal Desai	25 May 18	7.28 Yr.

Data below for Nippon India Pharma Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Health Care	99.45%

Asset Allocation

Asset Class	Value
Cash	0.55%
Equity	99.45%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 09 \| SUNPHARMA	12%	₹1,068 Cr	6,256,349
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	8%	₹660 Cr	1,000,031 ↓ -70,000
Lupin Ltd (Healthcare) Equity, Since 31 Aug 08 \| 500257	6%	₹518 Cr	2,683,991
Cipla Ltd (Healthcare) Equity, Since 31 May 08 \| 500087	6%	₹497 Cr	3,200,000
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 30 Jun 11 \| DRREDDY	6%	₹497 Cr	3,916,074 ↑ 453,904
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Sep 20 \| APOLLOHOSP	6%	₹486 Cr	648,795
Medplus Health Services Ltd (Healthcare) Equity, Since 30 Nov 22 \| 543427	4%	₹338 Cr	3,627,277
Vijaya Diagnostic Centre Ltd (Healthcare) Equity, Since 30 Sep 21 \| 543350	4%	₹310 Cr	2,886,684
GlaxoSmithKline Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Aug 22 \| GLAXO	3%	₹289 Cr	913,226 ↓ -5,938
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	3%	₹273 Cr	1,320,549 ↓ -208,803

9. Invesco India Infrastructure Fund

The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved.

Research Highlights for Invesco India Infrastructure Fund

Lower mid AUM (₹1,569 Cr).
Established history (17+ yrs).
Rating: 3★ (upper mid).
Risk profile: High.
5Y return: 29.06% (upper mid).
3Y return: 25.28% (lower mid).
1Y return: -5.70% (lower mid).
Alpha: 0.00 (bottom quartile).
Sharpe: -0.38 (bottom quartile).
Information ratio: 0.00 (bottom quartile).
Higher exposure to Industrials vs peer median.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~99%).
Largest holding Bharti Airtel Ltd (~6.4%).

Below is the key information for Invesco India Infrastructure Fund

Invesco India Infrastructure Fund Growth
Launch Date	21 Nov 07
NAV (04 Sep 25)	₹63.43 ↓ -0.37 (-0.58 %)
Net Assets (Cr)	₹1,569 on 31 Jul 25
Category	Equity - Sectoral
AMC	Invesco Asset Management (India) Private Ltd
Rating	☆☆☆
Risk	High
Expense Ratio	2.09
Sharpe Ratio	-0.38
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹16,507
31 Aug 22	₹18,498
31 Aug 23	₹22,765
31 Aug 24	₹38,345
31 Aug 25	₹35,557

Invesco India Infrastructure Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹627,226.
Net Profit of ₹327,226 Invest Now

Returns for Invesco India Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.3%
3 Month	-0.7%
6 Month	25.5%
1 Year	-5.7%
3 Year	25.3%
5 Year	29.1%
10 Year
15 Year
Since launch	11%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	33.2%
2023	51.1%
2022	2.3%
2021	55.4%
2020	16.2%
2019	6.1%
2018	-15.8%
2017	48.1%
2016	0.8%
2015	-2.6%

Fund Manager information for Invesco India Infrastructure Fund

Name	Since	Tenure
Amit Nigam	3 Sep 20	5 Yr.
Sagar Gandhi	1 Mar 25	0.5 Yr.

Data below for Invesco India Infrastructure Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Industrials	55.46%
Basic Materials	9.93%
Consumer Cyclical	8.6%
Communication Services	6.36%
Utility	5.32%
Real Estate	4.39%
Health Care	3.71%
Technology	2.91%
Energy	2.3%

Asset Allocation

Asset Class	Value
Cash	1.03%
Equity	98.97%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Bharti Airtel Ltd (Communication Services) Equity, Since 31 Aug 21 \| BHARTIARTL	6%	₹100 Cr	521,351
Delhivery Ltd (Industrials) Equity, Since 31 Aug 24 \| 543529	5%	₹72 Cr	1,698,708
Supreme Industries Ltd (Industrials) Equity, Since 30 Apr 24 \| 509930	4%	₹63 Cr	146,832 ↓ -3,558
PTC Industries Ltd (Industrials) Equity, Since 30 Sep 24 \| 539006	3%	₹53 Cr	35,841
Ramco Cements Ltd (Basic Materials) Equity, Since 31 Jul 23 \| RAMCOCEM	3%	₹53 Cr	448,912
ZF Commercial Vehicle Control Systems India Ltd (Consumer Cyclical) Equity, Since 30 Jun 23 \| ZFCVINDIA	3%	₹49 Cr	37,138
Power Grid Corp Of India Ltd (Utilities) Equity, Since 30 Apr 22 \| 532898	3%	₹48 Cr	1,650,305 ↓ -325,287
Indian Railway Catering And Tourism Corp Ltd (Industrials) Equity, Since 30 Apr 24 \| IRCTC	3%	₹47 Cr	642,726 ↓ -41,062
Honeywell Automation India Ltd (Industrials) Equity, Since 30 Sep 20 \| HONAUT	3%	₹46 Cr	11,992 ↑ 4,698
Dixon Technologies (India) Ltd (Technology) Equity, Since 30 Sep 22 \| DIXON	3%	₹46 Cr	27,141 ↓ -4,935

10. Kotak Infrastructure & Economic Reform Fund

The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly (at least 65%) equity and equity-related securities of companies involved in economic development of India as a result of potential investments in infrastructure and unfolding economic reforms.

Research Highlights for Kotak Infrastructure & Economic Reform Fund

Upper mid AUM (₹2,388 Cr).
Established history (17+ yrs).
Rating: 4★ (top quartile).
Risk profile: High.
5Y return: 29.48% (upper mid).
3Y return: 21.21% (bottom quartile).
1Y return: -8.73% (bottom quartile).
Alpha: -3.87 (bottom quartile).
Sharpe: -0.54 (bottom quartile).
Information ratio: 0.05 (upper mid).
Top sector: Industrials.
Top bond sector: Cash Equivalent.
Equity-heavy allocation (~99%).
Largest holding Bharti Airtel Ltd (~7.4%).

Below is the key information for Kotak Infrastructure & Economic Reform Fund

Kotak Infrastructure & Economic Reform Fund Growth
Launch Date	25 Feb 08
NAV (04 Sep 25)	₹64.405 ↓ -0.27 (-0.41 %)
Net Assets (Cr)	₹2,388 on 31 Jul 25
Category	Equity - Sectoral
AMC	Kotak Mahindra Asset Management Co Ltd
Rating	☆☆☆☆
Risk	High
Expense Ratio	2.01
Sharpe Ratio	-0.54
Information Ratio	0.05
Alpha Ratio	-3.87
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Aug 20	₹10,000
31 Aug 21	₹17,231
31 Aug 22	₹20,526
31 Aug 23	₹25,737
31 Aug 24	₹39,858
31 Aug 25	₹35,926

Kotak Infrastructure & Economic Reform Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹627,226.
Net Profit of ₹327,226 Invest Now

Returns for Kotak Infrastructure & Economic Reform Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Sep 25

Duration	Returns
1 Month	0.7%
3 Month	-0.8%
6 Month	23.7%
1 Year	-8.7%
3 Year	21.2%
5 Year	29.5%
10 Year
15 Year
Since launch	11.2%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	32.4%
2023	37.3%
2022	15.6%
2021	57.3%
2020	3.4%
2019	3.6%
2018	-19.6%
2017	45.3%
2016	9.2%
2015	-0.2%

Fund Manager information for Kotak Infrastructure & Economic Reform Fund

Name	Since	Tenure
Nalin Bhatt	1 Oct 23	1.92 Yr.

Data below for Kotak Infrastructure & Economic Reform Fund as on 31 Jul 25

Equity Sector Allocation

Sector	Value
Industrials	44.55%
Basic Materials	14.91%
Communication Services	10.97%
Consumer Cyclical	10.29%
Energy	8.35%
Utility	4.88%
Real Estate	2.05%
Financial Services	1.72%
Technology	1.21%

Asset Allocation

Asset Class	Value
Cash	0.97%
Equity	99.03%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Bharti Airtel Ltd (Communication Services) Equity, Since 30 Apr 20 \| BHARTIARTL	7%	₹177 Cr	927,000
Reliance Industries Ltd (Energy) Equity, Since 31 Mar 25 \| RELIANCE	5%	₹125 Cr	900,000
Larsen & Toubro Ltd (Industrials) Equity, Since 28 Feb 15 \| LT	5%	₹113 Cr	310,000
Shree Cement Ltd (Basic Materials) Equity, Since 31 Dec 11 \| 500387	5%	₹108 Cr	35,000
Solar Industries India Ltd (Basic Materials) Equity, Since 31 Oct 15 \| SOLARINDS	3%	₹77 Cr	54,000 ↓ -18,000
UltraTech Cement Ltd (Basic Materials) Equity, Since 31 Mar 15 \| 532538	3%	₹73 Cr	60,000
Kalpataru Projects International Ltd (Industrials) Equity, Since 31 Aug 17 \| KPIL	3%	₹73 Cr	639,927
Bosch Ltd (Consumer Cyclical) Equity, Since 30 Sep 24 \| 500530	3%	₹71 Cr	17,500
Kajaria Ceramics Ltd (Industrials) Equity, Since 31 Oct 16 \| 500233	3%	₹60 Cr	510,000 ↓ -90,000
VST Tillers Tractors Ltd (Industrials) Equity, Since 30 Apr 24 \| VSTTILLERS	3%	₹60 Cr	130,659

Disclaimer:
இங்கு வழங்கப்பட்ட தகவல்கள் துல்லியமானவை என்பதை உறுதிப்படுத்த அனைத்து முயற்சிகளும் மேற்கொள்ளப்பட்டுள்ளன. இருப்பினும், தரவின் சரியான தன்மை குறித்து எந்த உத்தரவாதமும் அளிக்கப்படவில்லை. எந்தவொரு முதலீடும் செய்வதற்கு முன் திட்ட தகவல் ஆவணத்துடன் சரிபார்க்கவும்.